Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29778738

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Jun
First author
Robinson GW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jun;19(6):720-721. doi: 10.1016/S1470-2045(18)30278-X.
    note
    Source null
    related pmid
    29778736
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Nov;15(11):659-660. doi: 10.1038/s41571-018-0071-6.
    note
    Source null
    related pmid
    30030473
    relationship
    Comment in

Authors and identifiers

  1. name
    Robinson GW
    type
    Author
  2. name
    Rudneva VA
    type
    Author
  3. name
    Buchhalter I
    type
    Author
  4. name
    Billups CA
    type
    Author
  5. name
    Waszak SM
    type
    Author
  6. name
    Smith KS
    type
    Author
  7. name
    Bowers DC
    type
    Author
  8. name
    Bendel A
    type
    Author
  9. name
    Fisher PG
    type
    Author
  10. name
    Partap S
    type
    Author
  11. name
    Crawford JR
    type
    Author
  12. name
    Hassall T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robinson GW
    type
    Author
  2. name
    Rudneva VA
    type
    Author
  3. name
    Buchhalter I
    type
    Author
  4. name
    Billups CA
    type
    Author
  5. name
    Waszak SM
    type
    Author
  6. name
    Smith KS
    type
    Author
  7. name
    Bowers DC
    type
    Author
  8. name
    Bendel A
    type
    Author
  9. name
    Fisher PG
    type
    Author
  10. name
    Partap S
    type
    Author
  11. name
    Crawford JR
    type
    Author
  12. name
    Hassall T
    type
    Author
bibliography ids
  1. nci-bib-937393d16e5f8045d4f5d13b
book metadata
content sha256
97e3506fbe2ec6125504a8cd77cdd2e56aa5c239f6b5b28d417d07188ed80bcc
document type
citation
dois
  1. 10.1016/S1470-2045(18)30204-3
electronic publication date
display
2018 May 16
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29778738
immutable id
pubmed:29778738@97e3506fbe2ec6125504a8cd77cdd2e56aa5c239f6b5b28d417d07188ed80bcc
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
768-784
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jun;19(6):720-721. doi: 10.1016/S1470-2045(18)30278-X.
    note
    Source null
    related pmid
    29778736
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Nov;15(11):659-660. doi: 10.1038/s41571-018-0071-6.
    note
    Source null
    related pmid
    30030473
    relationship
    Comment in
outcomes validated
false
pmid
29778738
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
41a09130ffef2630661a1d493dcd135f9b1db51b6d568117289df1ac3217e36e
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jun
precision
month
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29778738/
title
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice